These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7677689)

  • 1. Gynaecological complications of women treated with tamoxifen for breast cancer.
    Dew JE; Eden JA
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):198-200. PubMed ID: 7677689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial polyps, cystic glandular hyperplasia and atypical leiomyoma associated with tamoxifen therapy.
    Kimya Y; Cengiz C; Tolunay S
    Int J Gynaecol Obstet; 1994 Jul; 46(1):69-70. PubMed ID: 7805990
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
    Lee M; Piao J; Jeon MJ
    Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial lesions in patients undergoing tamoxifen therapy.
    De Muylder X; Neven P; De Somer M; Van Belle Y; Vanderick G; De Muylder E
    Int J Gynaecol Obstet; 1991 Oct; 36(2):127-30. PubMed ID: 1683314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal manipulation and gynaecological cancer: the tamoxifen dilemma.
    Ross D; Whitehead M
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):63-8. PubMed ID: 7742519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.
    Vosse M; Renard F; Coibion M; Neven P; Nogaret JM; Hertens D
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):58-63. PubMed ID: 11803101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer.
    Ryu KJ; Kim MS; Lee JY; Nam S; Jeong HG; Kim T; Park H
    JAMA Netw Open; 2022 Nov; 5(11):e2243951. PubMed ID: 36441547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does tamoxifen induce endometrial hyperplasia, carcinoma and polyps?
    van den Bosch T; Vandendael A
    S Afr Med J; 1994 Jun; 84(6):367-8. PubMed ID: 7740401
    [No Abstract]   [Full Text] [Related]  

  • 10. Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding.
    Fotiou S; Tserkezoglou A; Hadjieleftheriou G; Apostolikas N; Karydas I; Stravolemos K
    Anticancer Res; 1998; 18(1B):625-9. PubMed ID: 9584044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
    Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
    J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.
    Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM
    J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy].
    d'Arailh AS; Michy T; Pioud R; Dravet F; Classe JM
    Gynecol Obstet Fertil; 2007 Dec; 35(12):1215-9. PubMed ID: 18035581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
    Berlière M; Charles A; Galant C; Donnez J
    Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of endometrium treated with tamoxifen.
    Ismail SM
    J Clin Pathol; 1994 Sep; 47(9):827-33. PubMed ID: 7962652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifen.
    Biron-Shental T; Tepper R; Fishman A; Shapira J; Cohen I
    Gynecol Oncol; 2003 Aug; 90(2):382-6. PubMed ID: 12893204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy.
    Corley D; Rowe J; Curtis MT; Hogan WM; Noumoff JS; Livolsi VA
    Obstet Gynecol; 1992 Jan; 79(1):111-6. PubMed ID: 1727568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
    Hann LE; Gretz EM; Bach AM; Francis SM
    AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: analysis by menopausal status.
    McGonigle KF; Lantry SA; Odom-Maryon TL; Chai A; Vasilev SA; Simpson JF
    Cancer Lett; 1996 Mar; 101(1):59-66. PubMed ID: 8625283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.